More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...
A gene therapy for hearing loss. A drug that helps people quit e-cigarettes or vaping. An anesthetic whose main ingredient will be manufactured in the U.S. These are among the first nine therapies ...